Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway.

Heterochromatin protein 1 binding protein 3 (HP1BP3) is a recently described histone H1-related protein with roles in chromatin structure and transcriptional regulation. To explore the potential physiological role of HP1BP3, we have previously described an Hp1bp3(-/-) mouse model with reduced postnatal viability and growth. We now find that these mice are proportionate dwarfs, with reduction in body weight, body length, and organ weight. In addition to their small size, microcomputed tomography analysis showed that Hp1bp3(-/-) mice present a dramatic impairment of their bone development and structure. By 3 weeks of age, mice of both sexes have severely impaired cortical and trabecular bone, and these defects persist into adulthood and beyond. Primary cultures of both osteoblasts and osteoclasts from Hp1bp3(-/-) bone marrow and splenocytes, respectively, showed normal differentiation and function, strongly suggesting that the impaired bone accrual is due to noncell autonomous systemic cues in vivo. One major endocrine pathway regulating both body growth and bone acquisition is the IGF regulatory system, composed of IGF-1, the IGF receptors, and the IGF-binding proteins (IGFBPs). At 3 weeks of age, Hp1bp3(-/-) mice exhibited a 60% reduction in circulating IGF-1 and a 4-fold increase in the levels of IGFBP-1 and IGFBP-2. These alterations were reflected in similar changes in the hepatic transcripts of the Igf1, Igfbp1, and Igfbp2 genes. Collectively, these results suggest that HP1BP3 plays a key role in normal growth and bone development by regulating transcription of endocrine IGF-1 components.

[1]  G. Werther,et al.  IGFBP-2: The dark horse in metabolism and cancer. , 2015, Cytokine & growth factor reviews.

[2]  M. Bustin,et al.  HP1BP3 is a novel histone H1 related protein with essential roles in viability and growth , 2015, Nucleic acids research.

[3]  G. Werther,et al.  IGFBP-2 - taking the lead in growth, metabolism and cancer , 2015, Journal of Cell Communication and Signaling.

[4]  G. Athanasiadis,et al.  Heritability of Bone Mineral Density in a Multivariate Family-Based Study , 2014, Calcified Tissue International.

[5]  R. Crystal,et al.  Regulation of Insulin-like Growth Factor , 2013 .

[6]  Tim D. Spector,et al.  Genetics of osteoporosis from genome-wide association studies: advances and challenges , 2012, Nature Reviews Genetics.

[7]  C. Long,et al.  Genetic evidence that thyroid hormone is indispensable for prepubertal insulin‐like growth factor–I expression and bone acquisition in mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  S. Xuan,et al.  Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells , 2012 .

[9]  D. Bailey,et al.  Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  D. Larhammar,et al.  Evolution of the insulin-like growth factor binding protein (IGFBP) family. , 2011, Endocrinology.

[11]  Steven Boonen,et al.  Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. , 2010, The Journal of endocrinology.

[12]  C. Farquharson,et al.  The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. , 2010, The Journal of endocrinology.

[13]  S. Yakar,et al.  Elevated Serum Levels of IGF-1 Are Sufficient to Establish Normal Body Size and Skeletal Properties Even in the Absence of Tissue IGF-1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  K. Sjögren,et al.  The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.

[15]  M. Bouxsein,et al.  Serum IGF‐1 Determines Skeletal Strength by Regulating Subperiosteal Expansion and Trait Interactions , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  C. Rosen,et al.  Insulin-like growth factor-I and bone: lessons from mice and men , 2009, Pediatric Nephrology.

[17]  B. Clarke,et al.  Normal bone anatomy and physiology. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[18]  M. Bouxsein,et al.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.

[19]  G. Mazziotti,et al.  Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.

[20]  L. Melton,et al.  High Serum IGFBP‐2 Is Predictive of Increased Bone Turnover in Aging Men and Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Boonen,et al.  Impact of Androgens, Growth Hormone, and IGF‐I on Bone and Muscle in Male Mice During Puberty , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  J. Holly,et al.  The Role of Insulin-Like Growth Factor Binding Proteins , 2006, Neuroendocrinology.

[23]  A. Berdal,et al.  Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. , 2006, Endocrinology.

[24]  S. Ralston,et al.  Genetic regulation of bone mass and susceptibility to osteoporosis. , 2006, Genes & development.

[25]  A. Laib,et al.  The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. , 2006, Bone.

[26]  Mary L Bouxsein,et al.  Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.

[27]  S. Boonen,et al.  Growth Without Growth Hormone Receptor: Estradiol Is a Major Growth Hormone‐Independent Regulator of Hepatic IGF‐I Synthesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  T. Niu,et al.  The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. , 2005, Gene.

[29]  S. Mohan,et al.  Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. , 2005, The Journal of endocrinology.

[30]  C. Slemenda,et al.  The contribution of bone loss to postmenopausal osteoporosis , 1990, Osteoporosis International.

[31]  S. Mohan,et al.  The multi-functional role of insulin-like growth factor binding proteins in bone , 2005, Pediatric Nephrology.

[32]  L. Melton,et al.  A Potentially Deleterious Role of IGFBP‐2 on Bone Density in Aging Men and Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  T. Forrester,et al.  The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. , 2003, The Journal of clinical endocrinology and metabolism.

[34]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[35]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[36]  C. C. Pillai,et al.  Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.

[37]  R. Wilkins,et al.  Stat5b Is Required for Gh-induced Liver Igf-i Gene Expression Materials and Methods Animals , 2022 .

[38]  J. Terwilliger,et al.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. , 2001, Developmental biology.

[39]  R. Baron,et al.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.

[40]  T. Wood,et al.  Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.

[41]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Marcus,et al.  Peak Bone Mass , 2000, Osteoporosis International.

[43]  A. Hoeflich,et al.  Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain. , 1999, Endocrinology.

[44]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[45]  S. Mohan,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Studies on the Potential Mediators of Skeletal Changes Occurring during Puberty in Girls* , 2022 .

[46]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Hoeflich,et al.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. , 1999, Endocrinology.

[48]  L. Donahue,et al.  Insulin-Like Growth Factors and Bone: The Osteoporosis Connection Revisited , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[49]  T. Wagner,et al.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Doublier,et al.  Liver-Specific Expression of Human Insulin-Like Growth Factor Binding Protein-1 in Transgenic Mice: Repercussions on Reproduction, Ante- and Perinatal Mortality and Postnatal Growth. , 1997, Endocrinology.

[51]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[52]  S. Chua,et al.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.

[53]  M. Lewitt,et al.  Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. , 1995, Endocrinology.

[54]  J. Zerwekh,et al.  Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  C. Roberts,et al.  Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. , 1995, Endocrinology.

[56]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[57]  G. Saggese,et al.  Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. , 1993, The Journal of pediatrics.

[58]  R R Recker,et al.  Bone gain in young adult women. , 1992, JAMA.